activins and busulfan

activins has been researched along with busulfan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck, JF; Dressel, D; Grube, M; Klingebiel, T; Kroemer, HK; Maier, T; Ritter, CA; Siegmund, W; Sperker, B	1
Ameling, S; Bien, S; Boos, J; Hammer, E; Hempel, G; Kroemer, HK; Reimer, J; Ritter, CA; Völker, U	1

Trials

1 trial(s) available for activins and busulfan

Article	Year
Busulfan induces activin A expression in vitro and in vivo: a possible link to venous occlusive disease. Clinical pharmacology and therapeutics, 2003, Volume: 74, Issue:3 Topics: Activin Receptors; Activins; Antineoplastic Agents, Alkylating; Area Under Curve; Busulfan; Cell Line; Cells, Cultured; Cyclooxygenase 2; Cytokines; DNA, Complementary; Enzyme-Linked Immunosorbent Assay; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Inhibin-beta Subunits; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stem Cell Transplantation	2003

Article

Year

Busulfan induces activin A expression in vitro and in vivo: a possible link to venous occlusive disease.

Clinical pharmacology and therapeutics, 2003, Volume: 74, Issue:3

Topics: Activin Receptors; Activins; Antineoplastic Agents, Alkylating; Area Under Curve; Busulfan; Cell Line; Cells, Cultured; Cyclooxygenase 2; Cytokines; DNA, Complementary; Enzyme-Linked Immunosorbent Assay; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Inhibin-beta Subunits; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stem Cell Transplantation

2003

Other Studies

1 other study(ies) available for activins and busulfan

Article	Year
Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis. European journal of clinical pharmacology, 2012, Volume: 68, Issue:6 Topics: Activins; Antineoplastic Agents, Alkylating; Benzamides; Blood Coagulation; Busulfan; Cell Line, Tumor; Child; Dioxoles; Fibrinolysis; Gene Expression Profiling; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Human Umbilical Vein Endothelial Cells; Humans; Plasminogen Activator Inhibitor 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms	2012

Article

Year

Antineoplastic agent busulfan regulates a network of genes related to coagulation and fibrinolysis.

European journal of clinical pharmacology, 2012, Volume: 68, Issue:6

Topics: Activins; Antineoplastic Agents, Alkylating; Benzamides; Blood Coagulation; Busulfan; Cell Line, Tumor; Child; Dioxoles; Fibrinolysis; Gene Expression Profiling; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Human Umbilical Vein Endothelial Cells; Humans; Plasminogen Activator Inhibitor 1; RNA, Messenger; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

2012